Galecto is a clinical-stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets which are at the heart of fibrosis, inflammation, and cancer.
Genmab
55 followers
Mineralys Therapeutics
3 followers
MapLight Therapeutics
3 followers
Bionova Scientific
2 followers
Immunic Therapeutics
1 follower
MedRhythms
1 follower
Strand Therapeutics
3 followers
MBX Biosciences
2 followers
Arc Institute
4 followers
Dren Bio
1 follower
Trevi Therapeutics
1 follower
KPI Communications
4 followers